<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04728750</url>
  </required_header>
  <id_info>
    <org_study_id>FT7831</org_study_id>
    <nct_id>NCT04728750</nct_id>
  </id_info>
  <brief_title>Laparoscopic Enucleation of Frantz's Tumor of the Pancreas</brief_title>
  <official_title>Laparoscopic Enucleation of Frantz's Tumor of the Pancreas: Case Report and Literature Review</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tecnologico de Monterrey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tecnologico de Monterrey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study describes a 32-year-old female patient, in whom a preoperative imaging&#xD;
      diagnosis confirmed a mass in the junction of the body and tail of the pancreas. Based on the&#xD;
      anamnesis, on the preoperative diagnosis, and on the general status of the patient, the&#xD;
      decision was made to performed laparoscopic enucleation of the pancreatic tumor. The&#xD;
      operation and postoperative recovery passed without complications. A minimally invasive&#xD;
      surgical approach should be applied whenever the dimensions and the localization of the tumor&#xD;
      permits it, bearing in mind all the benefits and advantages that this surgical technique has&#xD;
      to offer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Actual">January 2, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Complete enucleation of a tumor in the pancreas</measure>
    <time_frame>December 2020</time_frame>
    <description>Performance of a laparoscopic enucleation of a tumor in the pancreas, and compared it with a conventional approach</description>
  </primary_outcome>
  <enrollment type="Actual">1</enrollment>
  <condition>Solid Pseudopapillary Neoplasm of the Pancreas</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Enucleation of a tumor of the pancreas</intervention_name>
    <description>Enucleation of a tumor in the pancreas is feasible and safe, as it offers a minimally invasive approach, and morbidities are fewer than open or conventional approach</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a diagnosed pancreatic tumor by image study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with benign tumor of the pancreas&#xD;
&#xD;
          -  Patients with a size tumor of less than 3 cm on the pancreas&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a size tumor greater than 3 cm on the pancreas&#xD;
&#xD;
          -  Malignant tumors of the pancreas&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Escuela Nacional de Medicina, Tecnologico de Monterrey</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <zip>76140</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 21, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2021</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tecnologico de Monterrey</investigator_affiliation>
    <investigator_full_name>Alejandro Ruiz Velasco Santacruz</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancrelipase</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

